Jolimont

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Childhood cancers1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials

Running trials

• Active, not recruiting

  A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

  NCT03473743· Phase 1/2· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· Phase 2· Janssen Research & Development, LLC· Source